Dylan Bird is an Analyst at Bay City Capital and has been with the firm since October 2006. Mr. Bird is responsible for developing financial analyses and conducting research for Bay City Capital's venture investments and related activities. He previously worked in the Research and Development group of Posit Science Corporation, a San Francisco based neurotechnology start-up company. Prior to Posit, Mr. Bird was a Robert T. Jones graduate fellow at the University of St. Andrews and holds a degree from Emory University in Neuroscience and French Literature. During his undergraduate studies, he worked as a Research Associate in the Department of Pathology at the Emory University School of Medicine.